NCT01449630View on ClinicalTrials.gov

A Study of LY3031207 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 24, 2011

Primary Completion Date

April 2, 2012

Study Completion Date

April 2, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY3031207

Administered orally

DRUG

Placebo

Administered orally

DRUG

Celecoxib

Administered orally

Trial Locations (1)

47710

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01449630 - A Study of LY3031207 in Healthy Subjects | Biotech Hunter | Biotech Hunter